<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=1400074&amp;fmt=gif">


First Look at the Distribution of Risk of Malignancy Pre- and Post-Test Using a Blood-Based Biomarker in Patients with Pulmonary Nodules in a Real-World Observational Study

Replay of a presentation with Michael Pritchett, DO, MPH where you will get a first-look at new data from Oracle on using a blood-based biomarker in patients with pulmonary nodules to help physicians determine the risk of cancer.


Contact our team to learn more

Contact us